Delivery Order SPE2DB22D2006-SPE2DB25FV5YX
Award Date
10/30/24
Potential Completion Date
10/31/24
Potential Value
$1.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,575.18 firm fixed-price delivery order is for the supply of XYOSTED 100 MG/0.5 ML AUTO-INJ 0.5ML, a pharmaceutical product. The contract has an ultimate completion date of August 14, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This federal contract award, identified as SPE2DB20D2014|SPE2DB25FA35X, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,480.22 firm fixed-price delivery order is for the supply of XYOSTED 100 MG/0.5 ML AUTO-INJ 0.5ML, a pharmaceutical product. The contract has an ultimate completion date of November 18, 2024 and was awarded on November 15, 2024. Amerisourcebergen, a for-profit organization, is registered in the System...
This federal contract award, with ID SPE2DB24D3015|SPE2DB24FFXUE, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, Corporate Office Division. The $1,642.47 firm fixed-price delivery order is for the supply of 4565821810 XYOSTED 100 MG/0.5 ML AUTO-INJ 0.5ML, a prescription medication. The contract has an ultimate completion date of September 17, 2024 and was awarded on September 16, 2024. Amerisourcebergen, a major pharmaceutical distributor,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,919.54 firm fixed-price delivery order is for the supply of XYOSTED 100 MG/0.5 ML AUTO-INJ 0.5ML, a medical product. The contract has an ultimate completion date of August 25, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,719.66 firm-fixed-price delivery order is for the supply of XYOSTED 75 MG/0.5 ML AUTO-INJ 0.5ML, a pharmaceutical product. The contract has an ultimate completion date of November 20, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,575.18, is a delivery order for the medication XYOSTED 100 MG/0.5 ML AUTO-INJ 0.5ML. The contract has a Firm Fixed Price pricing type and an ultimate completion date of March 5, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award SPE2DB20D3103|SPE2DB24FL7A4 was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which has a ceiling value of $2,434.10, is for the supply of XYOSTED 50 MG/0.5 ML AUTO-INJ 0.5ML pharmaceutical products. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of November 30, 2023. The...
This federal contract award, with ID SPE2DB22D1200|SPE2DB24FN3WJ, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, the Corporate Office division. The $1,627.02 firm fixed-price delivery order is for the supply of XYOSTED 100 MG/0.5 ML AUTO-INJ 0.5ML pharmaceutical products. This contract has an ultimate completion date of July 25, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded multiple federal contracts and Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $2,125.37 firm fixed-price delivery order is for the supply of the medication XYOSTED 50 MG/0.5 ML AUTO-INJ 0.5ML. The contract does not have a set-aside designation and has an ultimate completion date of July 25, 2024. Amerisourcebergen holds significant Indefinite Delivery Contracts (IDCs) with the DLA Troop Support Medical and the Department of...
This federal contract award with ID SPE2DB22D1202|SPE2DB25FUJT9 was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $4,780.26 firm fixed price delivery order is for the pharmaceutical product XYOSTED 100 MG/0.5 ML AUTO-INJ 0.5ML, with a completion date of November 18, 2024. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions...